EGFR activation and conformational "convergence": an emerging allosteric model from cancer mutations
{{output}}
Since its isolation nearly 50 years ago, the Epidermal Growth Factor Receptor (EGFR) has become one of the most extensively studied oncogenes. However, scarce data on the full-length receptor, together with its flexibility, has left critical aspects of its act... ...
